Avalo Therapeutics Inc (AVTX) Stock Analysis

Avalo Therapeutics Inc (AVTX) is a publicly traded company in the HEALTHCARE sector. It trades at $13.96, carries a market capitalization of $859.45M. This page summarizes the public market data, fundamentals, and frequently asked questions for AVTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $13.96
• Market Cap: $859.45M
• EPS: $-5.57
• 52-Week High: $24.27
• 52-Week Low: $4.06

Market Sentiment

Avalo Therapeutics Inc currently has a Neutral sentiment score of -0.03.

About Avalo Therapeutics Inc

None

GNG Research Analysis

GNG Research scores Avalo Therapeutics Inc (AVTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for AVTX.

Frequently Asked Questions

Does AVTX pay dividends?

Avalo Therapeutics Inc (AVTX) does not currently pay a regular dividend.

What is AVTX's market cap?

Avalo Therapeutics Inc (AVTX) has a market capitalization of $859.45M with a current stock price of $13.96.